Review and summary of health screening and early diagnosis and treatment of prostate cancer in China
10.3760/cma.j.cn115396-20200901-00265
- VernacularTitle:我国前列腺癌的健康筛查和早期诊疗方面的回顾和总结
- Author:
Dong WANG
1
;
Peiheng LI
;
Zhigang JI
;
Yi XIE
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院泌尿外科 100730
- From:
International Journal of Surgery
2020;47(9):577-581
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is one of the most common and fatal cancers worldwide. Although the incidence of prostate cancer in China is lower than that of European and American countries, it shows a trend of significant increase year by year. At the same time, the high proportion of advanced prostate cancer patients in China at the time of diagnosis has seriously affected the treatment effect. In recent years, with the joint efforts of the majority of Chinese medical staff, there has made great progress in the early screening, early diagnosis and treatment of prostate cancer. This article reviews and summarizes the progress in health screening and early treatment of prostate cancer in China in recent years to provide a basis for early clinical diagnosis and treatment of prostate cancer.
